Moderna reported $313M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 40.36M 68.31M Sep/2026
Agios Pharmaceuticals USD 37.84M 2.09M Sep/2026
Alnylam Pharmaceuticals USD 105.91M 8.8M Sep/2026
Amgen USD 6.39B 169M Sep/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Biogen USD 2.22B 159.9M Sep/2026
BioMarin Pharmaceutical USD 1.8B 13.54M Sep/2026
Celltrion KRW 126.69B 687.82M Jun/2026
Cspc Pharmaceutical CNY 3.09B 219.95M Dec/2025
Divis Laboratories Ltd INR 39.54B 7.18B Mar/2026
Gilead Sciences USD 1.9B 57M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Incyte USD 134.25M 21.71M Sep/2026
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Moderna USD 313M 33M Sep/2026
Organigram Holdings CAD 165.06M 29.9M Jun/2026
Pharma Mar EUR 49.53M 3.59M Jun/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Qiagen NV USD 311.35M 1.75M Jun/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Sarepta Therapeutics USD 876.12M 28.15M Sep/2026
Sartorius EUR 862.6M 30.7M Sep/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Ultragenyx Pharmaceutical USD 59M 0 Sep/2026
United Therapeutics USD 201.9M 8.1M Sep/2026
Vertex Pharmaceuticals USD 2.25B 480.2M Sep/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 5.95B 323.56M Jun/2026